Search hospitals > Oklahoma > Oklahoma City
IPS Research Company
Claim this profileOklahoma City, Oklahoma 73103
Global Leader in Depression
Global Leader in Attention Deficit Hyperactivity Disorder (ADHD)
Conducts research for Major Depressive Disorder
Conducts research for Migraine
Conducts research for Alzheimer's Disease
150 reported clinical trials
1 medical researcher
Summary
IPS Research Company is a medical facility located in Oklahoma City, Oklahoma. This center is recognized for care of Depression, Attention Deficit Hyperactivity Disorder (ADHD), Major Depressive Disorder, Migraine, Alzheimer's Disease and other specialties. IPS Research Company is involved with conducting 150 clinical trials across 79 conditions. There are 1 research doctors associated with this hospital, such as Louise M. Thurman.Top PIs
Clinical Trials running at IPS Research Company
Migraine
Dementia
Alzheimer's Disease
Psychomotor Agitation
Agitation in Dementia
Depression
Bipolar Disorder
Adolescent Health
Pediatric Migraine
Chronic Constipation
Lasmiditan
for Pediatric Migraine
This study is evaluating whether a drug may help reduce the frequency of migraines in children.
Recruiting2 awards Phase 3
Rimegepant
for Pediatric Migraine
This study is evaluating whether rimegepant is safe for children and adolescents.
Recruiting2 awards Phase 38 criteria
Ubrogepant
for Pediatric Migraine
This study is evaluating whether a drug can help prevent migraines in children and adolescents.
Recruiting1 award Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at IPS Research Company?
IPS Research Company is a medical facility located in Oklahoma City, Oklahoma. This center is recognized for care of Depression, Attention Deficit Hyperactivity Disorder (ADHD), Major Depressive Disorder, Migraine, Alzheimer's Disease and other specialties. IPS Research Company is involved with conducting 150 clinical trials across 79 conditions. There are 1 research doctors associated with this hospital, such as Louise M. Thurman.